Icahn Sours at Taste of Netflix's 'Poison Pill'

Slams stock move as 'poor corporate governance'
By Matt Cantor,  Newser Staff
Posted Nov 6, 2012 7:33 AM CST
Icahn Sours at Taste of Netflix's 'Poison Pill'
Netflix CEO Reed Hastings poses for a photo at Netflix headquarters in Los Gatos, Calif.   (AP Photo/Paul Sakuma)

Billionaire investor Carl Icahn isn't happy with Netflix's plan to avoid a takeover, and he told the SEC as much yesterday. In a filed statement, he called the company's share-diluting "poison pill" decision "an example of poor corporate governance," the Los Angeles Times reports. It's "particularly troubling" thanks to the poison pill's "low and discriminatory" trigger: If any shareholder moves to acquire more than 10% of the company, all other investors will be granted access to more shares. "As one of the company's largest shareholders, we are concerned about the poor corporate governance at Netflix that these and other actions reflect," Icahn said in the filing. (More Carl Icahn stories.)

Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.